Ryali Sriram
- SEC CIK
- 0001762893
No open-market purchases or sales filed in the past year.
Current role at each company
- CRBU Caribou Biosciences, Inc.Chief Financial Officeras of Feb 20, 2026
- CDXS Codexis, Inc.Chief Financial Officeras of Jan 2, 2024
- EIGR Eiger BioPharmaceuticals, Inc.Chief Financial Officeras of Mar 14, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Ryali Sriram as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
CRBU Caribou Biosciences, Inc.
Chief Financial Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jan 30, 2025 (view filing) | Jan 29 | 1 day | Ryali SriramChief Financial Officer | PPurchase | +17.4K | $1.42 | +$24.7K | New position17.4K after |
CDXS Codexis, Inc.
Chief Financial Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 12, 2023 (view filing) | Sep 8 | 4 days | Ryali SriramChief Financial Officer | PPurchase | +11.7K | $1.70 | +$19.8K | +10.4%123.4K after |
EIGR Eiger BioPharmaceuticals, Inc.
Chief Financial Officer1 trade
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Mar 14, 2022 (view filing) | Mar 14 | Same day | Ryali SriramChief Financial Officer | SSale | −2.27K | $5.60 | −$12.7K | −5.2%41.6K after |